SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-077005
Filing Date
2024-06-24
Accepted
2024-06-24 19:48:13
Documents
2
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4039
2 EX-24.POA virx-ex24_poa.htm EX-24.POA 11423
  Complete submission text file 0000950170-24-077005.txt   17140
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SUTRO BIOPHARMA, INC. 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address
Chung Jane (Reporting) CIK: 0001872398 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 241065907